abstract |
The present invention provides novel antibodies, and antibody fragments, that specifically bind to fibrillar amyloid, and not to the non-fibrillar peptide. Also provided are methods for generating, identifying, and isolating the antibodies and antibody fragments of the invention. The antibodies described herein are useful in the study, diagnosis, and treatment of Alzheimer's disease. |